Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemours Co Director's Dealing 2023

Mar 10, 2023

31561_dirs_2023-03-10_a9f96b19-bd13-46cb-8bf1-4c8202959318.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2023-03-01

Reporting Person: Sparks Edwin C (President, Titan Tech Chem Sol)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-01 Performance Stock Option (Right to Buy) $38.32 A 18370 Acquired 2033-03-01 Common Stock (18370) Direct

Footnotes

F1: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.